EastPharma Ltd. reported revenue results for the nine months of 2012. For the period, the company reported revenue of USD 170.8 million, down 14.1% from the same period in 2011 of USD 198.8 million. EastPharma's sales decrease was driven by decreased volumes in DEVA's Human Pharma Products businesses.
1st Jan change | Capi. | |
---|---|---|
+19.85% | 44.39B | |
+20.23% | 22.46B | |
+17.81% | 15.04B | |
+16.87% | 13.98B | |
+55.12% | 13.15B | |
-10.29% | 6.89B | |
-0.05% | 6.79B | |
+14.03% | 5.71B | |
-8.87% | 5.73B |